Investor Update

Reminder: Invitation to Roche’s Full Year Results 2019 Presentation


Roche will publish its Full Year Results for 2019 prior to the opening of the Swiss Stock Exchange on Thursday, 30 January 2020.

7:00 CET / 6:00 GMT / 1:00 AM EST / 10:00 PM PST (evening before)

Release will be e-mailed and posted on the Roche IR website > click here.
Presentation slides will be posted on the Roche IR website > click here.

We would like to invite all interested parties to participate or dial in to the event outlined below.

Thursday, 30 January 2020, London 
The Full Year Presentation will be held at the 
London Stock Exchange, 10 Paternoster Square, London EC4M 7LS >map

Presenters:

  • Severin Schwan, CEO Roche Group
  • Bill Anderson, CEO Roche Pharmaceuticals
  • Thomas Schinecker, CEO Roche Diagnostics
  • Alan Hippe, Chief Financial and IT Officer


Meeting information:
30 January 2020
Time (GMT): 
14:30 Registration 
15:00 Meeting starts 
17:00 Meeting ends, followed by a buffet reception

To register for the event, please follow the > link

Following the event we would also like to invite you to drinks and canapés to give you the opportunity to speak to management more informally.
Please make sure you have government recognised photographic identification with you, i.e. a passport, and allow enough time to go through the London Stock Exchange security check.

Live video webcast
This presentation can also be accessed through a live video webcast: > click here.

Access to Conference Call (pre-registration required)
You will receive phone numbers, passcode and your personal PIN to direct access the conference call by pre-registering here.
Should you have any issues with the registration, please dial the following numbers on the day of the conference call 10-15 minutes prior to conference start.

+41 (0) 58 310 5000 (Europe and ROW) or
+44 (0) 207 107 0613 (UK) or
+1 (1) 631 570 5613 (USA)

Replay 
A replay of the video webcast will be available on demand on the Roche website.
 

Best regards,


Karl Mahler
Head of Investor Relations and Roche Group Planning


Roche Investor Relations  
Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com
Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
   
Investor Relations North America  
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
Dr. Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com